Kevin P. Starr, 10% Owner at Jounce Therapeutics, Inc. (JNCE), sold 1,450,000 shares at $11.75 ($17.0M) on 2021-03-01, disclosed to the SEC on 2021-03-03.
Open-market sale of $17.0M JNCE by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| SAGE | SELL | 2018-04-19 | $10.0M | — | Filing → |
| MYOK | SELL | 2018-01-05 | $34.3M | — | Filing → |
| MYOK | SELL | 2017-10-04 | $6.1M | — | Filing → |